Natural Alternatives extends Wells Fargo credit facility to 2026

Published 23/06/2025, 21:22
Natural Alternatives extends Wells Fargo credit facility to 2026

CARLSBAD, Calif. - Natural Alternatives International, Inc. (NASDAQ:NAII), a nutritional supplement manufacturer with annual revenue of $125.48 million, has amended its credit facility with Wells Fargo Bank, extending the term to December 31, 2026, and modifying the borrowing capacity to $10 million, according to a press release statement issued Monday. InvestingPro analysis indicates the company maintains a healthy liquidity position with a current ratio of 2.51.

The nutritional supplement manufacturer, which specializes in formulating and marketing customized nutritional products, indicated the amended agreement will support its working capital needs as it pursues revenue growth and aims to return to sustainable profitability. Operating with gross profit margins of 5.72%, the company faces profitability challenges according to InvestingPro data.

"We are grateful for our long-standing relationship with Wells Fargo and we believe this amended credit facility is made possible by the strength of our balance sheet," said Mark A. Le Doux, Chairman and Chief Executive Officer of NAI.

Natural Alternatives International provides various services to its clients, including scientific research, clinical studies, product formulation, testing, and marketing support. The company also assists with packaging design, regulatory review, and international product registration.

The Carlsbad-based company’s announcement comes as part of its ongoing financial strategy. The credit facility amendment represents a continuation of the existing banking relationship between NAI and Wells Fargo.

The company noted in its statement that the facility is expected to be sufficient for its operational needs while it works toward its stated financial objectives. With a market capitalization of $20.45 million and trading at a price-to-book ratio of 0.27, InvestingPro analysis suggests the stock is currently undervalued.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.